PLN 50.9
(5.17%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 125.61 Million PLN | -29.09% |
2022 | 75.39 Million PLN | 53.74% |
2021 | 52.42 Million PLN | 60.06% |
2020 | 33 Million PLN | 410.61% |
2019 | 7.57 Million PLN | -60.49% |
2018 | 15.66 Million PLN | 92.73% |
2017 | 8.46 Million PLN | 336.12% |
2016 | 2.37 Million PLN | -156.63% |
2015 | 6.28 Million PLN | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 9.39 Million PLN | -21.44% |
2024 Q2 | 5.93 Million PLN | -49.87% |
2023 Q2 | 23.36 Million PLN | 56.73% |
2023 Q1 | 14.9 Million PLN | -42.57% |
2023 Q4 | 15.06 Million PLN | -6.25% |
2023 Q3 | 16.07 Million PLN | -31.21% |
2023 FY | - PLN | -29.09% |
2022 Q2 | 17.18 Million PLN | 6.48% |
2022 FY | - PLN | 53.74% |
2022 Q4 | 25.95 Million PLN | 18.2% |
2022 Q3 | 21.95 Million PLN | 27.77% |
2022 Q1 | 16.13 Million PLN | -5.09% |
2021 FY | - PLN | 60.06% |
2021 Q2 | 11.36 Million PLN | -37.27% |
2021 Q1 | 18.11 Million PLN | 124.02% |
2021 Q3 | 9.11 Million PLN | -19.78% |
2021 Q4 | 17 Million PLN | 86.56% |
2020 Q1 | 7.25 Million PLN | -7.57% |
2020 Q2 | 8.09 Million PLN | 11.57% |
2020 FY | - PLN | 410.61% |
2020 Q4 | 8.08 Million PLN | -14.04% |
2020 Q3 | 9.4 Million PLN | 16.26% |
2019 Q2 | -183.35 Thousand PLN | -103.38% |
2019 Q1 | 5.43 Million PLN | 0.0% |
2019 FY | - PLN | -60.49% |
2019 Q4 | 7.84 Million PLN | 11154.79% |
2019 Q3 | -70.97 Thousand PLN | 61.29% |
2018 Q3 | 3.89 Million PLN | 0.0% |
2018 FY | - PLN | 92.73% |
2018 Q1 | 3.58 Million PLN | 0.0% |
2017 FY | - PLN | 336.12% |
2016 FY | - PLN | -156.63% |
2015 FY | - PLN | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
BioMaxima S.A. | 3.28 Million PLN | -3725.0% |
Scope Fluidics S.A. | -17.24 Million PLN | 828.318% |
Voxel S.A. | 152.85 Million PLN | 17.82% |